Colgate Palmolive (India) Limited
Colgate Palmolive (India) Limited (COLPAL) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Fast Moving Consumer Goods›Fast Moving Consumer Goods›Personal Products›Personal Care
colgatepalmolive.co.in(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
|---|---|---|---|---|
| Sales | 1,463 Cr | 1,434 Cr | 1,520 Cr | 1,486 Cr |
| Operating expenses (approx.) | 965 Cr | 981 Cr | 1,054 Cr | 1,044 Cr |
| EBITDA | 498 Cr | 453 Cr | 465 Cr | 442 Cr |
| OPM % | 34.1% | 31.6% | 30.6% | 29.7% |
| Other income | 19 Cr | 18 Cr | 15 Cr | 39 Cr |
| Interest | 1 Cr | 1 Cr | 0.99 Cr | 0.97 Cr |
| Depreciation | 38 Cr | 38 Cr | 37 Cr | 36 Cr |
| Profit before tax | 478 Cr | 432 Cr | 442 Cr | 436 Cr |
| Tax % | 25.7% | 25.8% | 25.9% | 25.7% |
| Net profit | 355 Cr | 321 Cr | 328 Cr | 324 Cr |
| EPS (₹) | ₹13.05 | ₹11.79 | ₹12.04 | ₹11.91 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2025 | TTM |
|---|---|---|
| Sales | 6,040 Cr | Sign in for TTM |
| Operating expenses (approx.) | 4,082 Cr | Sign in for TTM |
| EBITDA | 1,958 Cr | Sign in for TTM |
| OPM % | 32.4% | Sign in for TTM |
| Other income | 139 Cr | Sign in for TTM |
| Interest | 4 Cr | Sign in for TTM |
| Depreciation | 163 Cr | Sign in for TTM |
| Profit before tax | 1,930 Cr | Sign in for TTM |
| Tax % | 25.5% | Sign in for TTM |
| Net profit | 1,437 Cr | Sign in for TTM |
| EPS (₹) | ₹52.83 | Sign in for TTM |
| Dividend payout % | 113.2% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 |
|---|---|
| Equity capital | 27 Cr |
| Reserves | 1,637 Cr |
| Borrowings | — |
| Other liabilities | 1,354 Cr |
| Total liabilities | 3,019 Cr |
| Fixed assets (net) | 776 Cr |
| CWIP | 38 Cr |
| Investments | 0 Cr |
| Loans & advances | 7 Cr |
| Inventories | 377 Cr |
| Trade receivables | 226 Cr |
| Cash & bank | 668 Cr |
| Other assets | 925 Cr |
| Total assets | 3,019 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 |
|---|---|
| Cash from operating activity | 1,394 Cr |
| Cash from investing | 56 Cr |
| Cash from financing | -1,671 Cr |
| Net cash flow | -221 Cr |
| Free cash flow (OCF − Capex) | 1,323 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2025 |
|---|---|
| ROCE % | 116.2% |
| ROE % | 86.3% |
| Debtor days | 14 |
| Inventory days | 87 |
| Days payable | 212 |
| Cash conversion cycle | -112 |
| Debt / equity | 0.00 |
| Current ratio | 1.65 |
| Net debt / EBITDA | -0.34 |
Compare with peers
Loading peers…